Semaglutide is a GLP-1 medication approved by the US Food and Drug Administration (FDA) that controls blood sugar levels in people with type 2 diabetes, reduces the risk of heart attack and stroke in people with heart disease and type 2 diabetes or obesity, and promotes weight loss in people with overweight and obesity
Insulin-induced drug eruptions and reliability of skin tests
Hsu 18 reported a case of a 52-year-old Hispanic woman with recalcitrant vitiligo that affected the face, trunk, and extremities who achieved near-complete cosmetic coverage using DHA sunless tanner, reporting that her vitiligo was unrecognizable in person
Diabetic retinopathy in people with diabetes In semaglutide studies in diabetes, early worsening of diabetic retinopathy complications was observed, likely related to rapid glucose improvement rather than a direct drug effect
These include: The rapid growth of fibroids that overwhelms the blood supply Large-sized tumors Twisted stalk for pedunculated fibroids: Pedunculated fibroids are fibroids that hang by a thin thread or stalk inside or outside the uterus
